BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The BioCalendar - ECPv6.17.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The BioCalendar
X-ORIGINAL-URL:https://thebiocalendar.com
X-WR-CALDESC:Events for The BioCalendar
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260630T080000
DTEND;TZID=America/Los_Angeles:20260630T170000
DTSTAMP:20260630T142002Z
CREATED:20260630T142002Z
LAST-MODIFIED:20260630T142002Z
UID:10683-1782806400-1782838800@thebiocalendar.com
SUMMARY:Outsourced Pharma Capabilities Update July 2026: Gene Therapy
DESCRIPTION:As gene therapy programs advance toward commercialization\, manufacturing decisions made early can have a lasting impact on product quality\, scalability\, and regulatory success.  \nIn this virtual event\, leading CDMOs share practical strategies for navigating process development\, GMP manufacturing\, tech transfer\, and commercial readiness.  \nLearn how the right development and manufacturing approach can reduce risk\, streamline scale-up\, and position your program for long-term success.
URL:https://thebiocalendar.com/event/outsourced-pharma-capabilities-update-july-2026-gene-therapy/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/06/Outsourced-Pharma-Capabilities-Update-July-2026-Gene-Therapy.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260630T110000
DTEND;TZID=America/Los_Angeles:20260630T120000
DTSTAMP:20260619T000052Z
CREATED:20260529T135221Z
LAST-MODIFIED:20260619T000052Z
UID:10553-1782817200-1782820800@thebiocalendar.com
SUMMARY:The Evolution and Future of Targeted Protein Degradation Chemistry
DESCRIPTION:Once a fringe idea in chemical biology\, targeted protein degradation (TPD) has become one of the most watched strategies in drug discovery. TPD has created new therapeutic opportunities for previously undruggable protein targets. Leading experts will discuss the design\, challenges\, and clinical promise of PROTACs in overcoming limitations of traditional small molecules. \nEver wonder: \nHow have PROTACS\, molecular glues\, and linker chemistries and their related research and development evolved over the past 20 years? \nHow we decide on the right modality and MoA? \nWhich discovery technologies are available to us? \nHow do they translate from animals to humans? \nHow are companies and academic groups approaching safety assessment for degraders\, particularly with respect to off‑target effects\, tissue specificity\, and long‑term protein knockdown? \nJoin us to get some answers directly from field experts.
URL:https://thebiocalendar.com/event/the-evolution-and-future-of-targeted-protein-degradation-chemistry/
LOCATION:Online webinar
CATEGORIES:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260630T110000
DTEND;TZID=America/Los_Angeles:20260630T120000
DTSTAMP:20260618T235913Z
CREATED:20260615T145041Z
LAST-MODIFIED:20260618T235913Z
UID:10608-1782817200-1782820800@thebiocalendar.com
SUMMARY:Breaking the Titer Ceiling: Smarter Media Design for Higher Productivity
DESCRIPTION:Discover how innovative media design strategies can help overcome productivity limitations in bioprocessing and drive higher titers without sacrificing product quality. In this webinar\, experts will share a data-driven\, bottom-up approach to media development using Design of Experiments (DOE) to identify the nutrients that have the greatest impact on cell culture performance. Learn how optimized basal and feed formulations can improve culture robustness\, alleviate metabolic bottlenecks\, and enhance productivity while maintaining critical quality attributes and process consistency.
URL:https://thebiocalendar.com/event/breaking-the-titer-ceiling-smarter-media-design-for-higher-productivity/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/06/06-30-26-KBI-eBlast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260630T120000
DTEND;TZID=America/Los_Angeles:20260630T130000
DTSTAMP:20260618T235845Z
CREATED:20260528T122037Z
LAST-MODIFIED:20260618T235845Z
UID:10540-1782820800-1782824400@thebiocalendar.com
SUMMARY:Residual DNA testing across biotherapeutics: dPCR workflows and a CDMO perspective
DESCRIPTION:Residual host cell DNA (residual DNA) is a critical quality attribute across biologics\, vaccines and advanced therapy modalities\, requiring sensitive and reproducible quantification to support process development\, in-process control and lot release. However\, traditional workflows can introduce variability and delay release timelines due to reliance on standard curves\, multiple manual steps and method complexity. \nIn this webinar\, we will outline digital PCR (dPCR) workflows and performance for residual DNA analysis across a range of expression systems\, including Vero\, Sf9/Baculovirus\, Pichia pastoris\, mouse\, HEK293\, CHO and E. coli. We will discuss how a standardized dPCR approach can simplify method deployment across diverse programs. \nKBI Biopharma will share real-life perspectives on implementing dPCR-based residual DNA workflows for CHO- and E. coli-derived programs\, including considerations for sample preparation and data interpretation. The session will also explore how extraction-free dPCR workflows can streamline in-process monitoring and lot release testing\, enabling faster decision-making and improved manufacturing efficiency. The webinar will conclude with practical guidance on assay selection and integration of residual DNA testing into development and manufacturing workflows. \nLearning objectives:\n– Understand dPCR-based residual DNA workflows and performance across multiple expression systems\n– Evaluate how dPCR can improve workflow efficiency and data quality\, including accuracy\, linearity\, and reduced turnaround time\n– Learn from a CDMO case study on implementing residual DNA testing\, including comparison to qPCR and the impact of extraction-free workflows on in-process monitoring and lot release
URL:https://thebiocalendar.com/event/residual-dna-testing-across-biotherapeutics-dpcr-workflows-and-a-cdmo-perspective/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/05/06-30-26-Qiagen-Reg-1920x250-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260701T110000
DTEND;TZID=America/Los_Angeles:20260701T120000
DTSTAMP:20260619T000522Z
CREATED:20260605T200441Z
LAST-MODIFIED:20260619T000522Z
UID:10574-1782903600-1782907200@thebiocalendar.com
SUMMARY:A Closer Look at How Single Use Consumables Drive Cost per Therapy
DESCRIPTION:The discussion will examine key manufacturing challenges and highlight where consumables add value\, where they introduce unnecessary complexity\, and how early upstream and downstream decisions impact long-term cost\, scalability\, and risk. Attendees will leave with key points to consider on how to approach consumables as a strategic part of manufacturing\, rather than a line-item cost.
URL:https://thebiocalendar.com/event/a-closer-look-at-how-single-use-consumables-drive-cost-per-therapy-2/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/06/07-01-26-Invetech-Reg-1920x250-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260701T130000
DTEND;TZID=America/Los_Angeles:20260701T140000
DTSTAMP:20260618T235854Z
CREATED:20260528T173004Z
LAST-MODIFIED:20260618T235854Z
UID:10545-1782910800-1782914400@thebiocalendar.com
SUMMARY:Reducing Particulate-Related Batch Risk in Bioprocessing: Moving from Detection to Prevention
DESCRIPTION:Rising regulatory expectations and increased scrutiny around particulate contamination are reshaping how risk is managed in bioprocessing. Particulate issues are often identified late in the process\, leading to operational disruption\, rework\, and increased validation burden. \nThis webinar explores how organizations can shift from reactive responses to proactive containment strategies. Using aggregated industry insights and representative case patterns\, we’ll examine where issues occur\, their operational impact\, and how low and ultra-low particulate container solutions can help reduce risk earlier and improve process reliability.
URL:https://thebiocalendar.com/event/reducing-particulate-related-batch-risk-in-bioprocessing-moving-from-detection-to-prevention/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/05/07-01-26-Thermo-LinkedIn-1280x720-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260707T110000
DTEND;TZID=America/Los_Angeles:20260707T120000
DTSTAMP:20260624T203118Z
CREATED:20260623T180209Z
LAST-MODIFIED:20260624T203118Z
UID:10636-1783422000-1783425600@thebiocalendar.com
SUMMARY:Solving Vector Yield Challenges in In Vivo CGT
DESCRIPTION:What does it take to turn breakthrough biology into successful in vivo therapies? \nAs innovations in synthetic biology\, RNA editing\, and gene therapy continue to accelerate\, vector design and manufacturing remain the critical link between scientific discovery and patient impact. \nJoin Chief Editor Erin Harris for a special Cell & Gene Live discussion with Robert Bell\, Ph.D.\, CSO at Ascidian Therapeutics\, and Karen Kozarsky\, Ph.D.\, Founder of Vector BioPartners. Together\, they’ll explore how capsid engineering affects transduction efficiency\, the tradeoffs between tissue specificity and manufacturability\, and what manufacturing teams need to know about real-world in vivo performance. \nDon’t miss this expert conversation on the challenges and opportunities shaping the future of in vivo cell and gene therapies. \nRegistration is free.
URL:https://thebiocalendar.com/event/solving-vector-yield-challenges-in-in-vivo-cgt/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/06/26_07_CGL_LinkedIn_1280x720.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260709T110000
DTEND;TZID=America/Los_Angeles:20260709T120000
DTSTAMP:20260618T235644Z
CREATED:20260615T143351Z
LAST-MODIFIED:20260618T235644Z
UID:10598-1783594800-1783598400@thebiocalendar.com
SUMMARY:The mRNA Therapeutics Regulatory Paradigm: A Closer Look
DESCRIPTION:In some ways\, it has been a quiet(er) year on the regulatory front for mRNA; there have been no mRNA-specific guidances released since the MHRA personalized cancer immunotherapy guidance and the EMA’s mRNA vaccine quality guidance — both of which were released in the winter of 2025. However\, there has been a flurry of activity at the FDA\, including new leadership appointments and the release of several guidances impacting the advanced therapies/personalized medicines sector. \nIn this discussion\, Advancing RNA Live Chief Editor Anna Rose Welch will dig into current events and recent guidance to identify the impacts these developments will have on the mRNA sector overall.
URL:https://thebiocalendar.com/event/the-mrna-therapeutics-regulatory-paradigm-a-closer-look/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/06/26_07_ARNA_HTML_600x300.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260710T110000
DTEND;TZID=America/Los_Angeles:20260710T120000
DTSTAMP:20260618T235602Z
CREATED:20260615T145422Z
LAST-MODIFIED:20260618T235602Z
UID:10612-1783681200-1783684800@thebiocalendar.com
SUMMARY:Modular vs Flexible Aseptic Filling Lines: Impacts on Speed\, Changeovers\, and Scale
DESCRIPTION:As biologics\, complex injectables\, and stricter regulatory requirements reshape sterile manufacturing\, facility design has become a critical factor in operational success. In this webinar\, learn how purpose-built modular aseptic filling facilities can improve contamination control\, manufacturing flexibility\, and scalability compared with retrofitted legacy sites. \nUsing real-world insights from Kindeva’s Bridgeton facility\, attendees will explore how modern facility design—from modular filling suites and independent environmental controls to warehousing\, cold storage\, and utilities—can accelerate operations\, support future growth\, and create a more resilient aseptic manufacturing ecosystem.
URL:https://thebiocalendar.com/event/modular-vs-flexible-aseptic-filling-lines-impacts-on-speed-changeovers-and-scale/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/06/07-10-26-Kindeva-eBlast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260710T120000
DTEND;TZID=America/Los_Angeles:20260710T140000
DTSTAMP:20260624T161737Z
CREATED:20260624T161735Z
LAST-MODIFIED:20260624T161737Z
UID:10645-1783684800-1783692000@thebiocalendar.com
SUMMARY:National Chronic Disease Day Luncheon Symposium at MassBio
DESCRIPTION:Join Good Days\, MassBio\, and leaders from across healthcare\, biotechnology\, patient advocacy\, and public policy for a focused discussion on advancing innovation and improving access for people living with chronic and complex conditions. \nObserved annually on July 10 (7/10)\, Chronic Disease Day highlights a sobering reality: seven out of 10 deaths in the United States are caused by chronic diseases\, including heart disease\, cancer\, and diabetes. These conditions claim more than 1.7 million lives each year and account for more than 90 percent of U.S. healthcare spending. \nAt the same time\, extraordinary advances in medicine are creating new possibilities for patients. Yet many individuals continue to face barriers to accessing the treatments and therapies they need. As healthcare leaders work to reduce the burden of chronic disease\, there is also an urgent need to ensure that innovation is affordable\, accessible\, and able to reach the patients who stand to benefit most. \nTo mark this year’s observance\, Good Days is hosting the Chronic Disease Day Leadership Luncheon at MassBio Hub. This exclusive convening\, limited to 80 attendees\, will bring together senior biotech executives\, healthcare leaders\, patient advocates\, and policymakers to explore how industry\, healthcare systems\, patient organizations\, and government can work together to improve outcomes for individuals living with chronic disease. \nWhy Attend\n\nConnect with leaders shaping the future of chronic disease policy\, research and care delivery.\nExplore challenges and opportunities in access to innovative therapies.\nGain insight into emerging trends in clinical research\, patient engagement\, and healthcare innovation.\nParticipate in conversations focused on improving affordability\, access\, and patient outcomes.
URL:https://thebiocalendar.com/event/national-chronic-disease-day-luncheon-symposium-at-massbio/
LOCATION:Cambridge\, MA\, Cambridge\, MA\, 02139\, United States
CATEGORIES:Symposium
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260712
DTEND;VALUE=DATE:20260716
DTSTAMP:20260504T221447Z
CREATED:20260504T221447Z
LAST-MODIFIED:20260504T221447Z
UID:10334-1783814400-1784159999@thebiocalendar.com
SUMMARY:Alzheimer's Association International Conference®
DESCRIPTION:Join distinguished basic scientists\, clinical researchers\, early career investigators\, clinicians and the care research community at the largest international conference on dementia science. Share theories\, breakthroughs and best practices while exploring opportunities to accelerate your work and elevate your career.
URL:https://thebiocalendar.com/event/alzheimers-association-international-conference-4/
LOCATION:London\, London\, United Kingdom
CATEGORIES:Academic Research
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260713
DTEND;VALUE=DATE:20260716
DTSTAMP:20251215T154751Z
CREATED:20251215T154751Z
LAST-MODIFIED:20251215T154751Z
UID:9649-1783900800-1784159999@thebiocalendar.com
SUMMARY:Global Biotech CEO Summit
DESCRIPTION:The Global Biotech CEO Summit\, unlike most meetings CEOs attend\, is not an investor conference nor is it a business development conference. Rather\, the Summit’s focus is on the challenges CEOs face in this rapidly changing environment and the obstacles they face leading their companies. The program is modeled after a think tank-style meeting with discussions led by subject matter experts with input from the CEOs. The CEOs benefit from the wisdom and experiences shared by other participating CEOs and the discussants. \nThe Summit operates under the Chatham House Rule to encourage open and frank conversations. The number of participants is limited to allow full engagement. Participation is gated; you have to apply to join this exclusive group. The Summit is closed to media and the sessions are not recorded in order to provide an extra layer of privacy. \nIf you are the CEO of a biotech company and are interested in attending this gathering\, please send an email to info@demy-colton.com with your contact details and a link to your company website. The organizers will respond quickly.
URL:https://thebiocalendar.com/event/global-biotech-ceo-summit/
LOCATION:Napa Valley\, Napa\, CA\, 94559\, United States
CATEGORIES:Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260713
DTEND;VALUE=DATE:20260717
DTSTAMP:20260603T113752Z
CREATED:20260603T113752Z
LAST-MODIFIED:20260603T113752Z
UID:10572-1783900800-1784246399@thebiocalendar.com
SUMMARY:The AAPS Summer Scientific Forum
DESCRIPTION:AAPS\, the convener of the pharmaceutical industry\, brings scientists working in pharmaceutical analysis and bioanalysis together in the Summer Scientific Forum. Dive deep into the latest research in these areas\, then cross-connect with other scientists in shared high-level sessions focused on regulatory issues that impact both disciplines. Discuss all of it in networking events designed to bring together all attendees.
URL:https://thebiocalendar.com/event/the-aaps-summer-scientific-forum/
LOCATION:Columbus\, Columbus\, OH\, United States
CATEGORIES:Forum
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260714T110000
DTEND;TZID=America/Los_Angeles:20260714T120000
DTSTAMP:20260624T203130Z
CREATED:20260623T180356Z
LAST-MODIFIED:20260624T203130Z
UID:10640-1784026800-1784030400@thebiocalendar.com
SUMMARY:The Risk And Reality Of 3D Printed Parts In Single-Use Workflows
DESCRIPTION:The trend toward 3D printing in process development is driven by early-stage benefit: engineers can create custom equipment for scale-up and scale-down initiatives and mitigation of process integration challenges. When sourcing unique or bespoke single-use parts is the bottleneck\, 3D printing offers a rapid way to keep development moving. However\, it comes with inherent risks. \n3D printing puts validation on the shoulders of the sponsor company. Issues like extractables and leachables\, integrity\, and regulatory scrutiny warrant serious consideration for anyone working toward GMP compliance. Building processes using components that may not exist\, now or ever\, outside your process lab could upend a pipeline before Phase 2. \nBioprocess Online Live’s expert panel\, including James Dean Vogel of The BioProcess Institute\, Vikash Kumar at Merck\, and Robert Dream\, an independent consultant and former biopharmaceutical executive\, will explore where and why 3D printing is being incorporated into process development workflows. They’ll also dig into some of the show-stopping hazards of “DIYing” your way to GMP.
URL:https://thebiocalendar.com/event/the-risk-and-reality-of-3d-printed-parts-in-single-use-workflows/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/06/26_07-BPOL-Internal-1280x720-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260715
DTEND;VALUE=DATE:20260720
DTSTAMP:20260504T221817Z
CREATED:20260504T221817Z
LAST-MODIFIED:20260504T221817Z
UID:10337-1784073600-1784505599@thebiocalendar.com
SUMMARY:BIO Asia–Taiwan 2026
DESCRIPTION:BIO Asia–Taiwan 2026 will be held July 15-19 at the TaiNEX 1 & 2 halls\, Nangang Exhibition Center\, Taipei. The event brings together bioindustry executives and investors from North America\, Europe and Asia to explore business opportunities and to engage with Taiwan’s growing biotech sector. The five-day gathering includes a three-day conference featuring 250+ internationally-renowned speakers\, company presentations from Asia and around the world\, BIO Partnering™ meetings\, a full program of symposia and workshops\, and an international exhibition.
URL:https://thebiocalendar.com/event/bio-asia-taiwan-2026/
LOCATION:Taipei\, Taipei\, Taiwan
CATEGORIES:Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260716T110000
DTEND;TZID=America/Los_Angeles:20260716T120000
DTSTAMP:20260618T235534Z
CREATED:20260612T113815Z
LAST-MODIFIED:20260618T235534Z
UID:10594-1784199600-1784203200@thebiocalendar.com
SUMMARY:The Site AI Playbook: Vendor Tools\, Homegrown Solutions & What's Working
DESCRIPTION:This webinar gives clinical research sites a practical look at how AI is being used today across source documentation\, regulatory compliance\, finance\, eSource\, and other site operations. CRIO’s Mike Wenger will join a panel of clinical site operators to discuss what’s working\, what’s overhyped\, and how sites can evaluate AI opportunities with more confidence. \nAttendees will walk away with the ability to:\n• Decide when to build\, configure\, or buy AI solutions\n• Identify high-impact AI use cases for site operations\n• Evaluate vendor claims and spot potential red flags\n• Apply real examples from eSource\, document review\, compliance\, and financial workflows\n• Use AI to improve speed\, quality\, and compliance across clinical trials
URL:https://thebiocalendar.com/event/the-site-ai-playbook-vendor-tools-homegrown-solutions-whats-working/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/06/07-16-26-CRIO-eBlast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260716T120000
DTEND;TZID=America/Los_Angeles:20260716T130000
DTSTAMP:20260709T105826Z
CREATED:20260709T105826Z
LAST-MODIFIED:20260709T105826Z
UID:10756-1784203200-1784206800@thebiocalendar.com
SUMMARY:An Agentic AI Approach to Predicting Immunotherapy Response
DESCRIPTION:Immune checkpoint inhibitors have transformed cancer care\, yet only about 1 in 5 patients respond to PD-1 blockade. Predicting who will respond remains one of oncology’s biggest unsolved challenges. \nIn this webinar\, scientists from Mithrl and Elephas will share how combining functional tumor profiling with agentic AI can reduce that uncertainty\, integrating real-time cytokine data from live tumor biopsies with large-scale genomic datasets to reveal the immune signatures that drive response. Attendees will get a firsthand look at how this approach was applied across 131 human tumor specimens and what it uncovered. \nKey topics include: \n\nWhat these findings mean for biomarker strategy\, patient selection\, and immunotherapy drug development\nHow Elephas’ elive platform captures real-time tumor responses to checkpoint inhibitors using live tumor fragments from patient biopsies\nHow Mithrl’s AI Scientific Decision Engine integrates multiple data types to generate biological insights\, without the manual data wrangling or pipeline engineering such analyses typically require\nThe distinct immune profiles and cytokine signatures identified across patient subgroups\, validated against public genomic datasets
URL:https://thebiocalendar.com/event/an-agentic-ai-approach-to-predicting-immunotherapy-response/
LOCATION:Online webinar
CATEGORIES:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260717T163000
DTEND;TZID=America/Los_Angeles:20260717T183000
DTSTAMP:20260504T221610Z
CREATED:20260504T221610Z
LAST-MODIFIED:20260504T221610Z
UID:10335-1784305800-1784313000@thebiocalendar.com
SUMMARY:Richmond BioHub Biotech & Beer
DESCRIPTION:The Richmond-Petersburg region is home to a dynamic network of biotech\, pharma\, medical device\, healthcare\, and life science professionals — and it’s also one of the best places in the country for craft beer lovers. \nJoin us for a Biotech & Beer\, a relaxed and lively networking event bringing together innovators from start-ups\, academia\, and industry\, alongside our regional ecosystem builders. Whether you’re a scientist\, entrepreneur\, investor\, or simply passionate about advancing life sciences in our region\, this is the perfect setting to make meaningful connections and enjoy great conversation over local brews. \nLet’s celebrate the power of collaboration — and good beer — in growing our biotech community.
URL:https://thebiocalendar.com/event/richmond-biohub-biotech-beer/
LOCATION:Richmond\, Richmond\, VA\, United States
CATEGORIES:Social
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260721T090000
DTEND;TZID=America/Los_Angeles:20260721T120000
DTSTAMP:20260630T200221Z
CREATED:20260630T200221Z
LAST-MODIFIED:20260630T200221Z
UID:10703-1784624400-1784635200@thebiocalendar.com
SUMMARY:BiotechTV's "US Science Summit"
DESCRIPTION:BiotechTV is organizing an exclusive in-person gathering that will take place on July 21\, 2026 in Kendall Square (Cambridge\, MA\, USA) of top biotech innovators\, patient advocates\, regulatory and policy experts\, science communicators\, and academic leaders.
URL:https://thebiocalendar.com/event/biotechtvs-us-science-summit/
LOCATION:Cambridge\, MA\, Cambridge\, MA\, 02139\, United States
CATEGORIES:Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260721T110000
DTEND;TZID=America/Los_Angeles:20260721T120000
DTSTAMP:20260618T235502Z
CREATED:20260615T145655Z
LAST-MODIFIED:20260618T235502Z
UID:10616-1784631600-1784635200@thebiocalendar.com
SUMMARY:When High-Stakes ADC Decisions Can't Wait for More Material or Better Data
DESCRIPTION:Early ADC development often requires critical decisions to be made with limited data and scarce material. In this webinar\, discover a streamlined analytical approach that enables accurate measurement of antibody-drug conjugate (ADC) concentration and drug-to-antibody ratio (DAR) without resource-intensive calibration assays. \nAttendees will learn how combining LC-MRM with a single UV280 measurement can generate reliable concentration data\, establish reusable linker-payload extinction coefficients\, and accelerate candidate evaluation. The session will provide practical insights into improving developability assessments and making more confident ADC decisions earlier in the development process.
URL:https://thebiocalendar.com/event/when-high-stakes-adc-decisions-cant-wait-for-more-material-or-better-data/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/06/07-21-26-Catalent-eBlast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260722T100000
DTEND;TZID=America/Los_Angeles:20260722T120000
DTSTAMP:20260618T235449Z
CREATED:20260611T145828Z
LAST-MODIFIED:20260618T235449Z
UID:10578-1784714400-1784721600@thebiocalendar.com
SUMMARY:Smart Sourcing: Patient Recruitment & Retention Showcase
DESCRIPTION:This 2-hour virtual showcase gives clinical teams a faster\, easier way to evaluate patient recruitment and retention partners. Attendees will hear short capability presentations\, compare providers side by side\, and ask questions directly during live Q&A. \nAttendees will gain: \n• A clearer view of available recruitment and engagement solutions\n• A more efficient way to compare potential partners without conference travel\n• Practical ideas to support enrollment timelines\, diversity goals\, and site experience\n• Direct access to provider insights during live Q&A\n• A stronger shortlist of partners to consider for upcoming studies\n• Takeaways to help reduce patient drop-off and improve recruitment planning
URL:https://thebiocalendar.com/event/smart-sourcing-patient-recruitment-retention-showcase/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/06/07-2026-CLSE-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260722T110000
DTEND;TZID=America/Los_Angeles:20260722T120000
DTSTAMP:20260714T200021Z
CREATED:20260630T203132Z
LAST-MODIFIED:20260714T200021Z
UID:10712-1784718000-1784721600@thebiocalendar.com
SUMMARY:Navigating AI Compliance in Life Sciences: FDA Policy Insights for AI Governance
DESCRIPTION:Life science organizations face critical questions about how to implement these tools while maintaining FDA compliance. Join us for a conversation on artificial intelligence in life sciences that bridges regulatory guidance with practical application\, giving quality professionals the insights they need to confidently adopt AI in their operations.
URL:https://thebiocalendar.com/event/navigating-ai-compliance-in-life-sciences-fda-policy-insights-for-ai-governance/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/06/07-22-26-MasterControl-Reg-1920x250-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260722T160000
DTEND;TZID=America/Los_Angeles:20260722T183000
DTSTAMP:20260618T235402Z
CREATED:20260611T183903Z
LAST-MODIFIED:20260618T235402Z
UID:10588-1784736000-1784745000@thebiocalendar.com
SUMMARY:BVS’ Biotech Community Event at the Pacific Center in San Diego
DESCRIPTION:We are very excited to announce our outdoor Biotech Community Event at the Pacific Center in San Diego. \nMark your calendars for a great opportunity to connect with industry leaders\, explore innovative products\, and mingle with fellow professionals in the biotech community. \n✨ What to Expect: \nVendor Exhibits: Discover a diverse range of exhibitors showcasing cutting-edge technology and services in the biotech space.\nNetworking Opportunities: Engage with fellow industry experts\, forge new connections\, and exchange ideas that could shape the future of biotech.\nDelicious Appetizers & Drinks: Enjoy summer-themed appetizers\, beer & wine\, and a Prosecco bar featuring a signature drink as you network and explore the vendor exhibits. \nWe are inviting all the Sterling Bay tenants and all local life science researchers and entrepreneurs in the surrounding area to attend. \nAdmission Details: \nFREE for life science job-related employees (including researchers\, scientists\, purchasing\, clinical\, manufacturing\, non-sales/bus dev positions etc.) from life science companies and research institutes.\n$200 fee for product and service providers who sell to the life science community (e.g. BVS suppliers\, business development/sales\, marketing\, lawyers\, consultants)\, which includes access to the event but does not include an exhibitor table. Exhibitor tables can be purchased separately. \nFor exhibitor tables\, please visit our website and register at: https://bvsconnection.com/events \nPlease feel free to invite others in the community that could benefit from attending. \nWe look forward to seeing you there!
URL:https://thebiocalendar.com/event/bvs-biotech-community-event-at-the-pacific-center-in-san-diego/
LOCATION:San Diego\, San Diego\, CA\, United States
CATEGORIES:Expo,Social
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/06/Pacific-Center-7.22.26.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260723T110000
DTEND;TZID=America/Los_Angeles:20260723T120000
DTSTAMP:20260630T200748Z
CREATED:20260630T141331Z
LAST-MODIFIED:20260630T200748Z
UID:10678-1784804400-1784808000@thebiocalendar.com
SUMMARY:Enhancing AAV Manufacturing Yield Through a Promoter-Optimized Mini-Helper Plasmid
DESCRIPTION:Discover how a simple redesign of the AAV helper plasmid could make gene therapy manufacturing more efficient and cost-effective. \nIn this webinar\, Samsung Biologics shares how its promoter-optimized mini-helper plasmid delivers up to a 6.5-fold increase in AAV yield\, reduces DNA synthesis costs\, and maintains high particle quality from lab scale to bioreactor production. \nYou’ll gain practical insights into the platform’s design\, transfection optimization\, and its potential to enable next-generation AAV manufacturing strategies.
URL:https://thebiocalendar.com/event/enhancing-aav-manufacturing-yield-through-a-promoter-optimized-mini-helper-plasmid/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/06/07-23-26-Samsung-eblast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260723T130000
DTEND;TZID=America/Los_Angeles:20260723T190000
DTSTAMP:20260601T133038Z
CREATED:20260601T133038Z
LAST-MODIFIED:20260601T133038Z
UID:10563-1784811600-1784833200@thebiocalendar.com
SUMMARY:MALSI Day 2026
DESCRIPTION:The 19th annual Massachusetts Life Sciences Innovation (MALSI) Day is the biggest day for life sciences startups and innovation in the Commonwealth of Massachusetts. This is a high-energy\, hands-on\, global event which brings together scientific leaders and business experts to mingle with scientists\, post-docs\, professors\, entrepreneurs\, innovators\, and venture capitalists. \nThe day features panel discussions\, emerging technology spinout showcase / pitches\, and features Tech Transfer Office startups and a networking reception. \nIt is the flagship event of life sciences in Massachusetts\, jointly and actively put together by the Massachusetts Life Sciences Center\, BioLabs\, LabCentral\, MassVentures and The Engine\, in partnership with many other major organizations supporting the life sciences start-up ecosystem in the Commonwealth.
URL:https://thebiocalendar.com/event/malsi-day-2026/
LOCATION:Cambridge\, MA\, Cambridge\, MA\, 02139\, United States
CATEGORIES:Networking,Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260723T160000
DTEND;TZID=America/New_York:20260723T183000
DTSTAMP:20260714T195915Z
CREATED:20260709T153452Z
LAST-MODIFIED:20260714T195915Z
UID:10758-1784822400-1784831400@thebiocalendar.com
SUMMARY:ARE and BVS' Scientific Summer Evening Event at 140 First Street\, Cambridge
DESCRIPTION:BVS in collaboration with Alexandria Real Estate Equities is hosting a Scientific Summer Evening Event at 140 First Street\, Cambridge! \nMark your calendars for a great opportunity to connect with industry leaders\, explore innovative products\, and mingle with fellow professionals in the biotech community. \n✨ What to Expect: \nVendor Exhibits: Discover a diverse range of exhibitors showcasing cutting-edge technology and services in the biotech space.\nNetworking Opportunities: Engage with fellow industry experts\, forge new connections\, and exchange ideas that could shape the future of biotech.\nDelicious Food & Drinks: Enjoy delicious food & refreshments as you network and explore the vendor exhibits. \nWe welcome the whole scientific community at 140 First Street and surrounding areas to join us for this exciting event! \nThis is a wonderful chance for everyone to come together\, share insights\, and celebrate the vibrant biotech landscape. \nAdmission Details: \nFREE for life science job-related employees (including researchers\, scientists\, purchasing\, clinical\, manufacturing\, non-sales/bus dev positions etc.) from life science companies and research institutes.\n$200 fee for product and service providers who sell to the life science community (e.g. BVS suppliers\, business development/sales\, marketing\, lawyers\, consultants)\, which includes access to the event but does not include an exhibitor table. Exhibitor tables can be purchased separately. \nFor exhibitor tables\, please visit our website and register at: https://bvsconnection.com/events \nPlease feel free to invite others in the community that could benefit from attending. \nWe look forward to seeing you there!
URL:https://thebiocalendar.com/event/are-and-bvs-scientific-summer-evening-event-at-140-first-street-cambridge-2/
LOCATION:Cambridge\, MA\, Cambridge\, MA\, 02139\, United States
CATEGORIES:Trade Show
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/07/BVS-Summer-Event-Flyer-07-23-26.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260724T110000
DTEND;TZID=America/Los_Angeles:20260724T120000
DTSTAMP:20260630T200730Z
CREATED:20260630T174022Z
LAST-MODIFIED:20260630T200730Z
UID:10698-1784890800-1784894400@thebiocalendar.com
SUMMARY:The Hidden Cost of CRO Change Orders and How Sponsors Can Best Manage Them
DESCRIPTION:CRO change orders can quickly become difficult to manage once a study is underway\, especially when budget revisions\, approvals\, comments\, and financial projections are spread across emails\, spreadsheets\, and disconnected systems. Join Clin.AI Founder and President Kalyan Obalampalli and clinical operations executive Leticia Tarilonte for a discussion on how sponsors can improve visibility into change order status\, track projections versus actual spend\, streamline approvals\, and maintain a complete audit trail throughout study execution. \nThis webinar will explore practical approaches for managing CRO change orders more efficiently\, reducing budget surprises\, and improving collaboration with vendors. \nRegister for the webinar on July 24\, 2026\, at 12:00 PM ET.
URL:https://thebiocalendar.com/event/the-hidden-cost-of-cro-change-orders-and-how-sponsors-can-best-manage-them/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/06/07-24-26-ClinAi-eBlast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260726
DTEND;VALUE=DATE:20260731
DTSTAMP:20260501T114859Z
CREATED:20260501T114859Z
LAST-MODIFIED:20260501T114859Z
UID:10318-1785024000-1785455999@thebiocalendar.com
SUMMARY:ADLM Annual Meeting
DESCRIPTION:July 26-30\, 2026 \nAnaheim Convention Center\nAnaheim\, CA\, USA \nSpeak your mind. Now accepting abstracts – inspire a global lab med community with your brilliance at #ADLM26. Accepted presenters will be part of a globally acclaimed scientific program. \nADLM 2026 (formerly the AACC Annual Scientific Meeting & Clinical Lab Expo) is a program of the Association for Diagnostics & Laboratory Medicine (ADLM). Great minds converge to discuss the latest science and prepare for what’s next in the field. Experience all this and more: \n\nConnect with global leaders in clinical chemistry\, molecular diagnostics\, mass spectrometry\, translational medicine\, lab management\, and other areas of breaking science in laboratory medicine.\nLearn about cutting edge technology at the ADLM Clinical Lab Expo featuring 750+ exhibitors and 200+ new products/services.\nHear vital research and learn about important changes in the field. With more than 250 educational opportunities in the form of lectures\, plenary sessions\, scientific sessions\, and roundtable sessions\, you can design an educational experience that meets your need to stay ahead of changes in the field.\n\nStart planning today. Save when you register early — registration is now open!
URL:https://thebiocalendar.com/event/adlm-annual-meeting/
LOCATION:Anaheim\, Anaheim\, CA\, United States
CATEGORIES:Annual Meeting
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260728T110000
DTEND;TZID=America/Los_Angeles:20260728T120000
DTSTAMP:20260714T200041Z
CREATED:20260701T172846Z
LAST-MODIFIED:20260714T200041Z
UID:10717-1785236400-1785240000@thebiocalendar.com
SUMMARY:Rewriting the Code: Advances and Challenges in Pediatric Gene Therapy
DESCRIPTION:Pediatric gene therapy is rapidly reshaping what is possible for children born with rare genetic diseases. Join Dr. Rachel Abu Taleb\, Medical Director\, Medical Affairs at Veristat\, for a look at the platforms driving clinical progress\, including AAV vectors\, lentiviral approaches\, and CRISPR-based gene editing. \nThrough examples such as Luxturna\, Zolgensma\, Casgevy\, and Lyfgenia\, this webinar will explore what recent approvals have taught the field across retinal\, neuromuscular\, and hematologic diseases. Dr. Abu Taleb will also discuss the safety\, regulatory\, long-term follow-up\, newborn screening\, and access challenges that continue to shape pediatric gene therapy development and delivery.
URL:https://thebiocalendar.com/event/rewriting-the-code-advances-and-challenges-in-pediatric-gene-therapy/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/07/07-28-26-Veristat-eBlast-700x200-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260729
DTEND;VALUE=DATE:20260731
DTSTAMP:20260630T200330Z
CREATED:20260630T200330Z
LAST-MODIFIED:20260630T200330Z
UID:10705-1785283200-1785455999@thebiocalendar.com
SUMMARY:Women Leaders in Life Sciences Law
DESCRIPTION:Benefit from Exceptional Opportunities for Professional Development\, Substantive Legal Discussion\, and Valuable Networking \nACI’s Summit for Women Leaders in Life Sciences Law is dedicated to providing the invaluable opportunities for networking and collaboration with the chance to meet\, engage with and learn from over 300 attorneys and executives from the biotech\, pharmaceutical\, and medical device industries and keep you up-to-date on the latest developments and challenges in the industry.
URL:https://thebiocalendar.com/event/women-leaders-in-life-sciences-law/
LOCATION:Boston\, MA\, 02210\, United States
CATEGORIES:Forum
END:VEVENT
END:VCALENDAR